This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Konstantinos Tepetes, MD; Rick Selby, MD; Marc Webb, MD; Juan R. Madariaga, MD; Shunzaburo Iwatsuki, MD, PhD; Thomas E. Starzl, MD, PhD

Arch Surg. 1995;130(2):153-156.

Abstract
Objective
To evaluate the frequency and outcome of liver transplantation for symptomatic, unresectable, benign hepatic neoplasms.

Design
Retrospective study.

Setting
Presbyterian University Hospital, a tertiary care referral center for liver transplantation affiliated with the University of Pittsburgh (Pa).

Patients
All 3239 liver transplant recipients at the University of Pittsburgh from January 1981 until January 1993.

Results
Twelve (0.37%) of 3239 patients required liver transplantation for benign, highly symptomatic hepatic neoplasms that were unresectable. Origins included adenoma (n=6), mesenchymal hamartoma (n=2), massive hepatic lymphangiomatosis (n=l), hilar fibrous angiodysplasia (n=1), focal nodular hyperplasia (n=1), and hemangioma (n=l). There were three perioperative deaths and two late deaths at 56 and 84 months. The remaining patients are alive, with follow-up ranging from 36 to 145 months. Median survival for the nine patients who survived the perioperative period is 88 months. The early deaths were attributable to hemorrhagic complications (n=2) and necrotizing pancreatitis (n=1). The two late deaths were due to disseminated aspergillosis and hepatitis-associated cirrhosis.

Conclusion
Patients with severe symptoms from benign hepatic neoplasms that are not resectable can be treated by total hepatectomy and orthotopic liver transplantation, with the expectation of good long-term results.

(Arch Surg. 1995;130:153-156)

Author Affiliations
From the Department of Surgery, University of Pittsburgh (Pa), Pittsburgh Transplant Institute.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Solid mesenchymal hamartoma in an adult: a case report.
Hernandez et al.
J. Clin. Pathol. 2006;59:542-545.
ABSTRACT | FULL TEXT  

Liver transplantation for massive hepatic haemangiomatosis causing restrictive lung disease
Keegan et al.
Br J Anaesth 2001;86:431-434.
ABSTRACT | FULL TEXT  

Long-term Results of Surgery for Liver Hemangiomas
Ozden et al.
Arch Surg 2000;135:978-981.
ABSTRACT | FULL TEXT